All Rights reserved, site designed by Yellohost.co.za
Credit: Pixabay/CC0 Public Domain The tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with …
Credit: Unsplash/CC0 Public Domain The combination of osimertinib and savolitinib showed clinically meaningful improvement in …
Credit: Unsplash/CC0 Public Domain Treatment with BAY 2927088 led to rapid, substantial, and durable responses …
Credit: CC0 Public Domain The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated …
Tumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination …
Credit: Unsplash/CC0 Public Domain According to two international studies presented at the ESMO Congress 2024, …
Credit: British Journal of Haematology (2024). DOI: 10.1111/bjh.19720 Using iPS cells generated from a patient …
Baseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause …
Prostate cancer cells. Credit: NIH Image Gallery A combination therapy improved progression-free survival in patients …
A new survey finds the majority of American men believe the first step in prostate …
Credit: Anna Tarazevich from Pexels Skin cancer is declining among younger adults in Sweden for …
Comparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and …